However, the application of AKT1 inhibitors in AP has become a controversial topic in recent years, mainly due to concerns regarding the impairment of acinar regeneration and the promotion of acinar-to-ductal metaplasia (Sarker and Steiger 2020). This evidence concerns the gene AKT1 and alkaline phosphatase measurement.